PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 14 |
| 2009 | 24 |
| 2010 | 28 |
| 2011 | 26 |
| 2012 | 33 |
| 2013 | 42 |
| 2014 | 32 |
| 2015 | 41 |
| 2016 | 56 |
| 2017 | 60 |
| 2018 | 51 |
| 2019 | 53 |
| 2020 | 117 |
| 2021 | 82 |
| 2022 | 71 |
| 2023 | 42 |
| 2024 | 43 |
| 2025 | 26 |
| 2026 | 12 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Lancet Oncol"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
Long-term exposure to wildfire-related PM2·5 and overall survival of older patients with lung cancer: a retrospective, registry-based cohort study.
- Zhang M, Wisnivesky JP, Qiu M, Danesh Yazdi M, Yin K, Wright RJ, Schwartz JD, Ekenga CC, Wright RO, Wei Y.
- Lancet Oncol. Author manuscript. 2026 Sep 15;27(10):1304-1313. doi: 10.1016/S1470-2045(26)00295-0.
- PMCID: PMC13661141
Zhang M, et al.Lancet Oncol. Author manuscript. 2026.PMCID: PMC13661141 -
Artificial intelligence-based tumour infiltrating lymphocyte quantification in patients with triple-negative breast cancer: an independent validation study.
- Dixon-Douglas JR, Drubay D, Salgado R, Acs B, van der Laak J, Yuan Y, Amgad M, Cooper L, Hagos Y, AbdulJabbar K, Meakin J, van Ginneken B, Yan H, Lemonnier J, Penault-Llorca F, Lacroix-Triki M, Joensuu H, Kellokumpu-Lehtinen PL, Loibl S, Denkert C, Viale G, Colleoni MA, Sotiriou C, Piccart M, Dieci MV, Demaria S, Kammler R, Wolff AC, Sparano JA, Adams S, Badve S, Gray RJ, Curigliano G, Salomon AV, Nielsen TO, Pusztai L, Ciompi F, Michiels S, Loi S; International Immuno-Oncology Biomarker Working Group.
- Lancet Oncol. Author manuscript. 2026 Sep;27(9):1181-1192. doi: 10.1016/S1470-2045(26)00339-6.
- PMCID: PMC13644576
Dixon-Douglas JR, et al.Lancet Oncol. Author manuscript. 2026.PMCID: PMC13644576 -
Global burden of cancer attributable to infections in 2024: a worldwide incidence analysis.
- Rumgay H, Georges D, Huang Y, Hirabayashi M, Shah R, de Martel C, Park JY, Soerjomataram I, Clifford GM.
- Lancet Oncol. 2026 Oct;27(10):1237-1248. doi: 10.1016/S1470-2045(26)00307-4.
- PMCID: PMC13619544
Rumgay H, et al.Lancet Oncol. 2026.PMCID: PMC13619544 -
Burden of cancer in Africa, 1990-2023: a systematic analysis from the Global Burden of Disease Study 2023.
- GBD 2023 Africa Cancer Risk Factors Collaborators.
- Lancet Oncol. 2026 Sep 15;27(10):1314-1340. doi: 10.1016/S1470-2045(26)00291-3.
- PMCID: PMC13619546
GBD 2023 Africa Cancer Risk Factors Collaborators.Lancet Oncol. 2026.PMCID: PMC13619546 -
An integrated lifestyle intervention for mitigation of adverse effects associated with androgen deprivation therapy for prostate cancer (STAMINA): a multicentre, randomised trial.
- Bourke L, Rosario DJ, Reale S, Ibeggazene S, Innes A, Scope A, Price G, Taylor S, Steed L, Sutton E, Stokes J, Hewison J, Morrissey D, Doherty P, Brown J, Meads D, O'Dwyer JL, Deniszczyc D, Greenfield DM, Mason M, Collinson M, Farrin A; STAMINA investigators.
- Lancet Oncol. 2026 Sep 4;27(10):1283-1294. doi: 10.1016/S1470-2045(26)00304-9.
- PMCID: PMC13619545
Bourke L, et al.Lancet Oncol. 2026.PMCID: PMC13619545 -
Genetic modification of the AJCC classification of papillary thyroid cancer: an international, multicentre, retrospective cohort study.
- Xing M, Lin S, Mathur A, Li Y, Bendlova B, Kuklikova V, Melo M, Jesus TT, Soares P, Colombo C, Fugazzola L, Mitsutake N, Matsuse M, Sako A, Estrada-Florez AP, Carvajal-Carmona LG, Bohórquez ME, Mian C, Vianello F, O'Neill CJ, Clifton-Bligh R, Czarniecka A, Jarzab B, Jung CK, Brahma B, Ladenson PW, Park YJ.
- Lancet Oncol. Author manuscript. 2025 Oct;26(10):1382-1392. doi: 10.1016/S1470-2045(25)00399-7.
- PMCID: PMC12969324
Xing M, et al.Lancet Oncol. Author manuscript. 2025.PMCID: PMC12969324 -
Cardiac radiosensitivity in the era of thoracic chemoradiotherapy and immunotherapy: a scoping review.
- Kim Y, Bates JE, Yoon HI, Grassberger C.
- Lancet Oncol. Author manuscript. 2026 Mar;27(3):e130-e140. doi: 10.1016/S1470-2045(25)00651-5.
- PMCID: PMC13492064
Kim Y, et al.Lancet Oncol. Author manuscript. 2026.PMCID: PMC13492064 -
Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer: a phase 3, multicentre, randomised, double-blind, placebo-controlled trial.
- DeWeese TL, Manzanera A, Sylvester J, Wheeler T, Schroeder T, Gejerman G, Chesnut G, Facelle TM, Garzotto MG, Pieczonka C, Gandhi NM, Sukin S, Liss MA, Tutrone R, Mehlhaff B, Savage SJ, Goody M, Vogt J, Rao S, Polanco MLS, Barone F, Nichols WG, Tak PP; PrTK03 study team.
- Lancet Oncol. Author manuscript. 2026 Jun;27(6):673-685. doi: 10.1016/S1470-2045(26)00071-9.
- PMCID: PMC13437160
DeWeese TL, et al.Lancet Oncol. Author manuscript. 2026.PMCID: PMC13437160 -
Derivation and validation of the AJCC9V pathological stage classification for HPV-positive oropharyngeal carcinoma: a multicentre registry analysis.
- Ho AS, Huang SH, O'Sullivan B, Luu M, Evans M, Ferris RL, Lewis JS Jr, Seethala RR, Yom SS, Mehanna H, Branstetter BF, Saba NF, Patel SG, Lydiatt WM, Zumsteg ZS.
- Lancet Oncol. Author manuscript. 2025 Jul 8;26(8):1113-1122. doi: 10.1016/S1470-2045(25)00281-5.
- PMCID: PMC13317659
Ho AS, et al.Lancet Oncol. Author manuscript. 2025.PMCID: PMC13317659 -
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG).
- Eochagain CM, Neuendorff NR, Gente K, Leipe J, Verhaert M, Sam C, de Glas N, Kadambi S, Canin B, Gomes F, Decoster L, Korc-Grodzicki B, Rostoft S, Battisti NML, Wildiers H.
- Lancet Oncol. Author manuscript. 2025 Feb;26(2):e90-e102. doi: 10.1016/S1470-2045(24)00404-2.
- PMCID: PMC13322125
Eochagain CM, et al.Lancet Oncol. Author manuscript. 2025.PMCID: PMC13322125